PL2195295T3 - Sposób wytwarzania formy kwasowej montelukastu w jonowym ciekłym środowisku - Google Patents

Sposób wytwarzania formy kwasowej montelukastu w jonowym ciekłym środowisku

Info

Publication number
PL2195295T3
PL2195295T3 PL08838092T PL08838092T PL2195295T3 PL 2195295 T3 PL2195295 T3 PL 2195295T3 PL 08838092 T PL08838092 T PL 08838092T PL 08838092 T PL08838092 T PL 08838092T PL 2195295 T3 PL2195295 T3 PL 2195295T3
Authority
PL
Poland
Prior art keywords
preparation
liquid medium
ionic liquid
montelukast acid
montelukast
Prior art date
Application number
PL08838092T
Other languages
English (en)
Inventor
Chul-Hyun Park
Eun-Ju Park
Choong-Hahn Kim
Suk Man Jang
Eun Jung Lim
Young Kil Chang
Gwan Sun Lee
Jaeheon Lee
Original Assignee
Hanmi Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40549354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2195295(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Science Co Ltd filed Critical Hanmi Science Co Ltd
Publication of PL2195295T3 publication Critical patent/PL2195295T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL08838092T 2007-10-09 2008-10-01 Sposób wytwarzania formy kwasowej montelukastu w jonowym ciekłym środowisku PL2195295T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020070101486A KR101072896B1 (ko) 2007-10-09 2007-10-09 이온성 액체 매개체를 이용한 몬테루카스트산의 제조 방법
EP08838092A EP2195295B1 (en) 2007-10-09 2008-10-01 Method for the preparation of montelukast acid in ionic liquid medium
PCT/KR2008/005794 WO2009048236A1 (en) 2007-10-09 2008-10-01 Method for the preparation of montelukast acid in ionic liquid medium

Publications (1)

Publication Number Publication Date
PL2195295T3 true PL2195295T3 (pl) 2013-06-28

Family

ID=40549354

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08838092T PL2195295T3 (pl) 2007-10-09 2008-10-01 Sposób wytwarzania formy kwasowej montelukastu w jonowym ciekłym środowisku

Country Status (18)

Country Link
US (1) US8426599B2 (pl)
EP (1) EP2195295B1 (pl)
JP (1) JP5210389B2 (pl)
KR (1) KR101072896B1 (pl)
CN (1) CN101808998B (pl)
AR (1) AR068755A1 (pl)
CA (1) CA2701912C (pl)
CL (1) CL2008002996A1 (pl)
DK (1) DK2195295T3 (pl)
ES (1) ES2398732T3 (pl)
HR (1) HRP20130103T1 (pl)
MX (1) MX2010001864A (pl)
PE (2) PE20091369A1 (pl)
PL (1) PL2195295T3 (pl)
PT (1) PT2195295E (pl)
RU (1) RU2436774C1 (pl)
TW (1) TWI350284B (pl)
WO (1) WO2009048236A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
CN103570618A (zh) * 2013-09-30 2014-02-12 浙江车头制药股份有限公司 一种孟鲁司特钠盐的制备方法
CN105294556A (zh) * 2014-06-06 2016-02-03 上海迪赛诺化学制药有限公司 一种制备孟鲁司特酸的方法
KR20210042412A (ko) 2018-09-06 2021-04-19 주식회사 이노파마스크린 천식 또는 파킨슨병 치료를 위한 방법 및 조성물
KR102181155B1 (ko) * 2019-09-26 2020-11-20 대봉엘에스 주식회사 이온성 액체를 매개로 한 에피나코나졸의 신규 제조방법
CN111892535B (zh) * 2020-08-27 2023-04-11 鲁南制药集团股份有限公司 一种孟鲁司特钠的合成方法
CN111961083B (zh) * 2020-08-27 2022-11-25 鲁南制药集团股份有限公司 一种孟鲁司特钠中间体化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19875039I2 (de) 1990-10-12 2003-05-22 Merck Frosst Canada Inc Ungesaettigte Hydroxyalkylchinolinsaeuren als Leukotrien-Antagonisten
TW448160B (en) * 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
US5523477A (en) 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
WO2005074935A1 (en) * 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Montelukast free acid polymorphs
MXPA06012220A (es) 2004-04-21 2007-07-18 Teva Pharma Procesos para preparar sodio de montelukast.
JP2006089463A (ja) * 2004-08-24 2006-04-06 Sumitomo Chemical Co Ltd アリールエーテル類の製造方法
WO2006064269A2 (en) * 2004-12-17 2006-06-22 Cipla Limited Salts of leukotriene antagonist montelukast
GB0500029D0 (en) * 2005-01-04 2005-02-09 Univ Belfast Basic ionic liquids
AU2006302237C1 (en) 2005-10-07 2012-11-08 The University Of Alabama Multi-functional ionic liquid compositions
EP1783117A1 (en) 2005-11-04 2007-05-09 Esteve Quimica, S.A. Process for the preparation of a leukotriene antagonist and intermediates thereof
EP1968943B1 (en) 2005-12-13 2013-01-23 MSN Laboratories Limited An improved process for the preparation of montelukast and its pharmaceutically acceptable salts
US20090182148A1 (en) * 2005-12-23 2009-07-16 Harmander Singh Pal Chawla Process for the manufacture of montelukast sodium
WO2007096889A2 (en) * 2006-02-27 2007-08-30 Chemagis Ltd. Process for preparing montelukast and salts thereof
KR100774088B1 (ko) 2006-12-14 2007-11-06 한미약품 주식회사 몬테루카스트의 제조방법 및 이에 사용되는 중간체

Also Published As

Publication number Publication date
EP2195295B1 (en) 2013-01-23
KR20090036349A (ko) 2009-04-14
JP2011500555A (ja) 2011-01-06
DK2195295T3 (da) 2013-05-06
US8426599B2 (en) 2013-04-23
CA2701912A1 (en) 2009-04-16
MX2010001864A (es) 2010-03-15
PT2195295E (pt) 2013-02-28
CA2701912C (en) 2013-04-02
KR101072896B1 (ko) 2011-10-17
ES2398732T3 (es) 2013-03-21
PE20131219A1 (es) 2013-11-16
TWI350284B (en) 2011-10-11
HRP20130103T1 (hr) 2013-02-28
US20110105757A1 (en) 2011-05-05
CN101808998B (zh) 2012-10-24
JP5210389B2 (ja) 2013-06-12
CN101808998A (zh) 2010-08-18
CL2008002996A1 (es) 2009-04-13
EP2195295A1 (en) 2010-06-16
PE20091369A1 (es) 2009-10-01
EP2195295A4 (en) 2011-04-13
TW200920737A (en) 2009-05-16
WO2009048236A1 (en) 2009-04-16
AR068755A1 (es) 2009-12-02
RU2436774C1 (ru) 2011-12-20

Similar Documents

Publication Publication Date Title
ZA201004887B (en) Method for improving the hydrolysis stability of ionic liquids
EP2163545A4 (en) IONIC LIQUID AND METHOD FOR THE PRODUCTION THEREOF
IL238896A0 (en) A liquid formulation containing a high concentration of antibody
IL209740A0 (en) Methods for the production of ips cells using non-viral approach
PT2379730E (pt) Método para a preparação de dióis
TWI350284B (en) Method for the preparation of montelukast acid in ionic liquid medium
EP2619285A4 (en) SYSTEM AND METHOD FOR PRODUCING LIQUID FUELS
EP2156141A4 (en) METHOD FOR TUNING A VIRTUAL CARD AND SYSTEM THEREFOR
EP2520558A4 (en) ALKYLATION METHOD EMPLOYING IONIC LIQUID AS CATALYST
HK1184643A1 (en) Method for suspending particles in alcoholic liquid composition and corresponding liquid composition
IL210787A0 (en) Methods for the cytological analysis of cervical cells
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
EP2110438A4 (en) METHOD FOR INCREASING THE CONTENT OF DOCOSAHEXAENIC ACID IN AN OIL AND FAT-CONTAINING MATERIAL OR IN OIL AND FAT
HK1150163A1 (en) Method for preparing trifluoromethanesulphinic acid
PL2421625T3 (pl) Sposób odwadniania cieczy jonowej
EP2270145A4 (en) NEW HYALURONIC ACID BINDING PROTEIN AND METHOD FOR MEASURING HYALURONIC ACID THEREFOR
EP2069307A4 (en) PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
EP2233138A4 (en) ASSOCIATION WITH ETODOLAC IN LIQUID ION FORM
AP2012006315A0 (en) Methods and compositions for the removal of impurities from an impurity-loaded ionic liquid.
EP2260847A4 (en) AQUEOUS LIQUID CONTAINING GATIFLOXACIN
PL2534098T3 (pl) Sposób i urządzenie do regulowania stężenia kwasów albo ługów
HRP20120988T8 (en) Method for the stereoselective preparation of amino acid derivatives
PL2275399T3 (pl) Ciekła kompozycja kwasu mlekowego i sposób jej otrzymywania
TWI370016B (en) N-substituted amino acid ionic liquid and preparation method thereof
PL389579A1 (pl) Sposób oznaczania cieczy jonowych za pomocą technik elektromigracyjnych